> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-022.md). # BRE 022 ## Barium Titanate Nanoparticles and TTFields Sensitization in Breast Cancer **Clinical Cancer Name:** Breast Carcinoma **Common Cancer Name:** Breast Cancer ## Source Yoon, Y. N., Lee, D. S., Park, H. J., et al. (2020). *Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields.* *Scientific Reports, 10, 2560.* *** ## BRS Score **BRS:** 9.0 / 10\ **STEMD:** S9 / T8 / E9 / M10 / D9\ **External Evidence Level:** High experimental preclinical evidence ## Score Interpretation BRE-022 receives a very strong BRS because it provides direct experimental evidence that barium titanate nanoparticles increased sensitivity to TTFields in treatment-resistant breast cancer models. Its strongest value is mechanistic and discovery-oriented because it introduces ferroelectric nanoparticle amplification as a possible way to strengthen electric-field response. *** ## Entry Summary BRE-022 asks a major breast cancer question: Can nanoparticles make treatment-resistant breast cancer cells more sensitive to Tumor Treating Fields? This study tested barium titanate nanoparticles with TTFields in breast cancer models. Barium titanate is important because it has ferroelectric properties, meaning it can interact strongly with electric fields. In simple language: If TTFields are like applying an electric-field signal to cancer cells, barium titanate nanoparticles may help amplify that signal locally around the cells. BREXAtlas identifies BRE-022 as a major nanoparticle-sensitization entry. *** ## What BREXAtlas Found BREXAtlas found that BRE-022 supports this mechanism chain: * Ferroelectric nanoparticles * Localized electric-field amplification * Enhanced TTFields sensitivity * Increased tumor-cell stress * Enhanced anti-tumor response This makes BRE-022 one of the strongest early entries connecting nanotechnology, electric fields, and breast cancer response. *** ## Questions This BRE Helps Answer ### What cancer models were studied? What BREXAtlas found:\ BRE-022 involved breast cancer models, including: * MCF7 * BT-549 * MDA-MB-231 These models are important because they represent breast cancer contexts where electric-field sensitization may be tested. ### Why are treatment-resistant breast cancer cells important? Treatment-resistant cancer cells are harder to kill with standard approaches. If a sensitizer makes resistant cells more vulnerable, it may open a path for combination treatment research. What BREXAtlas found:\ BRE-022 supports that barium titanate nanoparticles increased sensitivity to TTFields in treatment-resistant breast cancer models. ### What does “ferroelectric amplification” mean? Ferroelectric materials can respond strongly to electric fields. In this entry, the key idea is that barium titanate nanoparticles may amplify local electric-field effects. What BREXAtlas found:\ BRE-022 supports ferroelectric nanoparticle amplification as a mechanism that may enhance TTFields response. *** ## Study Classification | Category | Classification | | ---------------------------------- | -------------------------------------------------------- | | Study Type | Experimental TTFields + nanoparticle sensitization study | | Tissue Category | Breast carcinoma | | Common Cancer Name | Breast cancer | | Cell Lines / Models | MCF7, BT-549, MDA-MB-231 | | Intervention | TTFields + barium titanate nanoparticles | | Direct Electric-Field Evidence | Yes | | Nanotechnology Evidence | Yes | | Suitable for Frequency Index | Pending detailed parameter extraction | | Suitable for Mechanism Index | Yes | | Suitable for Nanobioelectric Index | Yes | | Suitable for Breast Cancer Index | Yes | *** ## Mechanisms ### MEC-034: Ferroelectric Nanoparticle Amplification Barium titanate nanoparticles may amplify local electric-field effects. ### MEC-020: Dielectrophoretic / Electric-Field Force Effects BRE-022 connects with the broader field-force logic from earlier TTFields entries. ### MEC-063: Dielectric Sensitivity Cancer cells may respond differently when local electromagnetic properties are altered. ### MEC-064: Apoptotic Signaling Enhancement The extraction identifies apoptotic signaling enhancement as part of the observed anti-tumor activity. ### MEC-065: Electromagnetic Stress Amplification Nanoparticles may increase local electric-field stress around cancer cells. *** ## Discovery ### DISC-014: Ferroelectric Amplification of TTFields BRE-022 strongly supports a major BREXAtlas discovery: TTFields may be amplified by ferroelectric nanoparticles. This discovery matters because it suggests future bioelectric oncology may combine: * electric-field therapy * nanotechnology * tumor sensitization * treatment-resistant cancer targeting *** ## Connections to Other BRE Entries ### Connected to BRE-021 BRE-021 emphasized frequency optimization, field distribution, and electromagnetic-field geometry. BRE-022 provides a concrete experimental direction: use ferroelectric nanoparticles to amplify local electric-field response. ### Connected to BRE-016 BRE-016 focused on field concentration and localized cellular stress during cytokinesis. BRE-022 extends the field-concentration idea into nanoparticle-assisted amplification. ### Connected to BRE-020 BRE-020 discussed combination therapy and molecular pathway changes. BRE-022 expands combination logic beyond radiation and chemotherapy into nanotechnology-assisted TTFields sensitization. ### Connected to BRE-018 BRE-018 showed that TTFields may create treatment vulnerability by reducing DNA repair capacity. BRE-022 shows a different vulnerability route: increasing electric-field sensitivity through nanoparticles. ### Connected to Future Breast Cancer Entries BRE-022 becomes a foundation entry for the Breast Cancer section of the BREXAtlas Encyclopedia because it identifies specific breast cancer models and a possible sensitization strategy. *** ## Research Gaps Identified ### RG-107: Nanoparticle Dose Gap More work is needed to determine optimal barium titanate nanoparticle dose and delivery. ### RG-108: Frequency-Nanoparticle Interaction Gap It remains unclear how TTFields frequency interacts with nanoparticle amplification. ### RG-109: Cell-Line Specificity Gap More detailed comparison is needed across MCF7, BT-549, and MDA-MB-231. ### RG-110: Normal Tissue Safety Gap More research is needed to determine whether nanoparticle-assisted TTFields selectively affects cancer cells without harming normal tissue. ### RG-111: Clinical Translation Gap Preclinical evidence is promising, but clinical translation requires safety, delivery, dosing, and treatment-integration studies. *** ## Why This Entry Matters For researchers, BRE-022 is important because it links electric-field therapy with nanotechnology. For patients and families, the idea is simple: Some breast cancer cells resist treatment. This study suggests nanoparticles may make those cells more sensitive to electric-field therapy. This is not proof of a ready clinical treatment. It is strong preclinical evidence that the combination deserves deeper research. *** ## Entry Conclusion BRE-022 marks a major expansion of the BREXAtlas Encyclopedia. Earlier entries focused on TTFields mechanisms, DNA repair, mitosis, and field optimization. BRE-022 adds nanotechnology-assisted electric-field amplification in breast cancer. The central question emerging from this entry is: Can ferroelectric nanoparticles make resistant breast cancer cells more vulnerable to Tumor Treating Fields? For BREXAtlas, BRE-022 is a key bridge between bioelectric oncology and precision nanotechnology. --- # Agent Instructions This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com. ## Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter: ``` GET https://www.brexatlas.org/bre-001/bre-022.md?ask=&goal= ``` `ask` is the immediate question: it should be specific, self-contained, and written in natural language. `goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.